Form 8-K PHIBRO ANIMAL HEALTH For: Nov 10

�

�

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

�

�

FORM 8-K

�

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

�

Date of report (Date of earliest event reported): November 10, 2014

�

Phibro Animal Health Corporation

�

(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)

�

Delaware	�	01-36410	�	13-1840497
(State or other jurisdiction of incorporation)	�	(Commission File Number)	�	(IRS Employer Identification No.)

�

Glenpointe Centre East, 3rd Floor

300 Frank W. Burr Boulevard, Suite 21

Teaneck, New Jersey 07666-6712

(Address of Principal Executive Offices, including Zip Code)

�

(201) 329-7300

(Registrant’s telephone number, including area code)

�

Not Applicable

(Former name or former address, if changed since last report)

�

Check the appropriate box below if this Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

�

� Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

� Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

� Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

� Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

�

�

�

ITEM 8.01 OTHER EVENS.

�

On November 10, 2014, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 23, 2014, to stockholders of record at the close of business on December 3, 2014. A copy of the press release announcing the dividend is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

�

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

�

(d) Exhibits

�

Exhibit Number	�	Description
99.1	�	Press Release, dated November 10, 2014.�

�

SIGNATURES

�

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

�

�	PHIBRO ANIMAL HEALTH CORPORATION Registrant
�	�
Date: November 10, 2014	�
�	�
�	By:�	/s/ Thomas G. Dagger
�	Name:�	Thomas G. Dagger
�	Title:	Senior Vice President, General Counsel
�	�	and Corporate Secretary

�

�

Exhibit 99.1

�

�

�

Phibro Animal Health Corporation Declares Quarterly Dividend

�

TEANECK, N.J., November 10, 2014 (GLOBE NEWSWIRE) – The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 23, 2014, to stockholders of record at the close of business on December 3, 2014.

�

About Phibro Animal Health Corporation

�

Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture.

�

For further information, please visit www.pahc.com.

�

Contact:

Richard Johnson

Chief Financial Officer, Phibro Animal Health Corporation

+1 201-329-7300

[email protected]

�

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
• PennyGuard Launches a Subscription Cancellation App and Budget Tracker
• Implantica announces successful completion of first RefluxStop® procedures in the U.S.